Format

Send to

Choose Destination
Clin Infect Dis. 2016 Dec 15;63(12):1539-1557.

Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Author information

1
Uniformed Services University of the Health Sciences, Bethesda, Maryland.
2
Centers for Disease Control and Prevention, Atlanta, Georgia.
3
McGill University Health Centre, Montreal, Quebec, Canada.
4
University of Virginia School of Medicine, Charlottesville.
5
Ramón y Cajal University Hospital, Madrid, Spain.
6
Walter Reed National Military Medical Center, Bethesda, Maryland.
7
Gonçalo Moniz Research Center, FIOCRUZ, Salvador, Bahia, Brazil.
8
Carmel Medical Center, Haifa, Israel.
9
Federal University of Rio Grande do Norte, Natal, Brazil.
10
Bill and Melinda Gates Foundation, Seattle, Washington.

Abstract

It is important to realize that leishmaniasis guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. The IDSA and ASTMH consider adherence to these guidelines to be voluntary, with the ultimate determinations regarding their application to be made by the physician in the light of each patient's individual circumstances.

KEYWORDS:

cutaneous leishmaniasis; immunocompromised host; leishmaniasis diagnostic testing; mucosal leishmaniasis; visceral leishmaniasis

PMID:
27941143
DOI:
10.1093/cid/ciw742
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center